Summary
Two families with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency due to compound heterozygosity are described. All patients have a 13 bp insertion in exon 11 of one allele at the MCAD gene locus. In the other allele patients in one of the families harbour the prevalent G985 mutation, and the other family possess an unidentified mutation causing reduced levels of MCAD mRNA. We demonstrate that the disease in these families is inherited as an autosomal recessive trait. Individuals heterozygous for the mutations show heterozygous/control levels of β-oxidation activities in cultured fibroblasts (9.1–16.3 pmol/min per mg protein; control 10–17 pmol/min per mg protein), and in the excretion of the ‘β-oxidation metabolites’, hexanoylglycine (<2 µmol/mmol creatinine), suberylglycine (<2 µmol/mmol creatinine) and phenylpropionylglycine (<2 µmol/mmol creatinine). This shows that there is no ‘negative dominance’ from the mutant monomeric protein onto the normal ones, in accordance with the finding of low levels of MCAD mRNA from the allele harbouring the 13 bp insertion as well as the allele with the unidentified mutation, and the low steady-state level of enzyme protein expressed from the G985-bearing allele. In the family possessing the G985 and the 13 bp insertion mutations, two asymptomatic compound heterozygous individuals were detected. They exhibited elevated excretion of hexanoylglycine (5–15 µmol/mmol creatinine) and suberylglycine (4–13 µmol/mmol creatinine), together with β-oxidation activity in fibroblasts in the homozygous range (2.9 pmol/min per mg protein), showing a lack of correlation between the genotype, some biochemical parameters and the clinical phenotype.
Similar content being viewed by others
References
Andresen BS, Knudsen I, Winter V et al (1992) Mutations in the medium-chain acyl-CoA dehydrogenase (MCAD) gene in compound heterozygous patients with MCAD deficiency.Am J Hum Genet 51: A642.
Andresen BS, Kølvraa S, Bross P et al (1993) A silent A to G mutation in exon 11 of the medium-chain acyl-CoA dehydrogenase (MCAD) gene.Hum Mol Genet 2: 488.
Bennett MJ, Allison F, Pollitt RJ, Variend S (1990) Fatty acid oxidation defects as causes of unexpected death in infancy. In Tanaka K, Coates PM, eds.Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan R Liss, 349–364.
Blakemore AIF, Singleton H, Pollitt R et al (1991) The frequency of the G985 MCAD mutation in the general population.Lancet 337: 298–299.
Bross P, Andresen BS, Winter V et al (1993) Cooverexpression of bacterial GroESL chaporonins partly overcomes non-productive folding and tetramer assembly ofE. coli expressed human medium-chain acyl-CoA dehydrogenase (MCAD) carrying the prevalent disease-causing K304E mutation.Biochim Biophys Acta 1182: 264–274.
Cao A, Furbetta M, Ximenes A et al (1981) Beta-thallassemia type in southern Sardinia.J Med Genet 18: 196–198.
Chang JC, Kan YW (1979) Beta-thallassemia: A nonsense mutation in man.Proc Natl Acad Sci USA 76: 2886–2889.
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Anal Biochem 162: 156–159.
Coates PM, Indo Y, Young D, Hale DE, Tanaka K (1992) Immunological characterization of variants medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency.Pediatr Res 31: 34–38.
Duran M, Hofkamp M, Rhead WJ, Saudubray JM, Wadman SK (1986) Sudden child death and ‘healthy’ affected family members with medium-chain acyl-CoA dehydrogenase deficiency.Pediatrics 78: 1052–1057.
Gregersen N, Kieding K, Kølvraa S (1979)N-acylglycines: Gas chromatographic mass spectrometric identification and determination in urine by selected ion monitoring (SIM).Biomed Mass Spectrom 6: 439–443.
Gregersen N, Rosleff F, Kølvraa S, Hobolth N, Rasmussen K, Lauritzen R (1980) Non-ketotic C6-C10-dicarboxylic aciduria: Biochemical investigations of two cases.Clin Chim Acta 102: 179–189.
Gregersen N, Kølvraa S, Rasmussen K et al (1983) General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): Quantitative urinary excretion pattern of 23 biologically significant organic acids in 3 cases.Clin Chim Acta 132: 181–191.
Gregersen N, Andresen BS, Bross P et al (1991a) Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Identification of a lys329 to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein inE. coli.Hum Genet 86: 545–551.
Gregersen N, Winter V, Andresen BS et al (1991b) Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point mutation (G985) in the MCAD gene.Clin Chim Acta 203: 23–34.
Gregersen N, Winter V, Curtis D et al (1993) Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: The prevalent mutation G985 (K304E) is subject to a strong founder effect from Northwestern Europe.Hum Hered 43: 342–350.
Ikeda Y, Keese SM, Fenton WA, Tanaka K (1987) Biosynthesis of four rat liver mitochondria acyl-CoA dehydrogenases: In vitro synthesis, import into mitochondria, and processing of their precursors in a cell-free system and in cultured cells.Arch Biochem Biophys 252: 662–674.
Jensen TG, Andresen BS, Bross P et al (1992) Expression of wild type and mutant medium-chain acyl-CoA dehydrogenase (MCAD) cDNA in eucaryotic cells.Biochim Biophys Acta 1180: 65–72.
Kølvraa S, Gregersen N, Christiansen E, Hobolth N (1982) In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: Evidence for a defect in general acyl-CoA dehydrogenase.Clin Chim Acta 126: 53–67.
Kølvraa S, Gregersen N, Blakemore A et al (1991) The most common mutation causing medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is strongly associated with a particular haplotype in the region of the gene.Hum Genet 87: 425–429.
Manning NJ, Olpin SE, Pollitt RJ, Webley J (1990) A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.J Inher Metab 13: 58–68.
Matsubara Y, Narisawa K, Tada K et al (1991) Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards.Lancet 338: 552–553.
Rinaldo P, O'Shea JJ, Coates PM, Hale DE, Stanley S, Tanaka K (1988) Medium-chain acyl-CoA dehydrogenase deficiency: Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine.N Engl J Med 319: 1308–1313.
Roe CR, Coates PM (1989) Acyl-CoA dehydrogenase deficiencies. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.The Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw-Hill, 889–914.
Roe CR, Millington DS, Maltby DA, Kinnebrew P (1986) Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes.J Pediatr 108: 13–18.
Rüdiger N, Heinsvig EM, Hansen FA, Bolund L, Faergeman O, Gregersen N (1991) Identification of 3 deletions in the LDL receptor gene in 25 Danish families with familial hypercholesterolemia.Clin Genet 39: 451–462.
Saudubray JM, Coude FX, Demaugre F, Johnson C, Gibson KM, Nyhan WL (1982) Oxidation of fatty acids in cultured fibroblasts: A model system for the detection and study of defects in beta-oxidation.Pediatr Res 16: 877–881.
Tanaka K, Yokota I, Coates PM et al (1992) Mutations in the medium-chain acyl-CoA dehydrogenase (MCAD) gene.Hum Mutat 1: 271–279.
Trecartin RF, Liebhaber SA, Chang JC et al (1981) Beta-thallassemia in Sardinia is caused by a nonsense mutation.J Clin Invest 68: 1012–1017.
Workshop Report (1992) Mutations causing medium-chain acyl-CoA dehydrogenase deficiency: A collaborative compilation of the data from 172 patients. In Coates PM, Tanaka K, eds.New Developments in Fatty Acid Oxidation. New York: Wiley-Liss, 499–506.
Yokota I, Tanaka K, Coates PM, Ugarte M (1990) Mutations in medium-chain acyl-CoA dehydrogenase deficiency.Lancet 336: 748.
Yokota I, Coates PM, Hale DE, Rinaldo P, Tanaka K (1991) Molecular survey of a prevalent mutation, A-985 to G transition, and identification of five infrequent mutations in the medium-chain acyl-CoA dehydrogenase gene in 55 patients with medium-chain acyl-CoA dehydrogenase deficiency.Am J Hum Genet 47: 1280–1291.
Yokota I, Saijo T, Vockley J, Tanaka K (1992) Impaired tetramer assembly of variant medium-chain acyl-CoA dehydrogenase with a glutamate or aspartate substitution for lysine 304 causing instability of the protein.J Biol Chem 267: 26004–26010.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gregersen, N., Winter, V., Lyonnet, S. et al. Molecular genetic characterization and urinary excretion pattern of metabolites in two families with MCAD deficiency due to compound heterozygosity with a 13 base pair insertion in one allele. J Inherit Metab Dis 17, 169–184 (1994). https://doi.org/10.1007/BF00711614
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00711614